Enhanced Product Sample Clauses

Enhanced Product. In consideration of additional premium paid, the Enhanced Product provides a commitment of no new High-Risk Individual Stop Loss Amounts or rate-ups for Covered Persons’ medical conditions upon Policy renewal. When indicated on the Stop Loss Application And Schedule Of Insurance, it is the dollar amount of Eligible Claim Expenses per covered family (eligible Employees or Covered Units and their enrolled dependents) that you must pay prior to any family individual Stop Loss benefit becoming payable under this Policy. A Covered Person that has Eligible Claim Expenses under the plan expected to exceed the Individual Stop Loss Amount. The Covered Person may have a separate higher Individual Stop Loss Amount or may be excluded from coverage under this policy as indicated on the Stop Loss Application And Schedule Of Insurance. The dollar amount of Eligible Claim Expenses for a High-Risk Covered Person that you must pay before any individual Stop Loss benefit is payable under this policy as indicated in the Stop Loss Application And Schedule Of Insurance.

Enhanced Product. (i) USSC shall have the right and option to obtain Rights with respect to Enhanced Products in accordance with this Section 2(c)(i). If during the Term, VITEX or any of its Affiliates conceives, develops or obtains any rights, title or interest in an Enhanced Product, ["****" indicates material omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment.] VITEX shall (i) furnish full written details thereof to USSC, (ii) provide to USSC any prototype thereof in VITEX's possession or control, and (iii) provide USSC a detailed research and development plan including proposals for research personnel, budgets and time frames for the development of such Enhanced Product. USSC shall have a period of **************** thereafter (the "Enhanced Product Exclusive Evaluation Period") to exclusively evaluate such research and development plan and to determine whether or not USSC wishes to obtain Rights in respect thereof. During the Enhanced Product Exclusive Evaluation Period, VITEX shall answer USSC questions concerning the Enhanced Products, shall promptly forward to USSC any additional Technology or prototypes related to such Enhanced Product that it may conceive, develop or come into possession or control of during the Enhanced Product Exclusive Evaluation Period together with its best good faith estimate of the expected transfer price thereof. If USSC determines in its discretion to exercise its right and option with respect to such Enhanced Product and USSC gives notice thereof no later than three (3) days after the expiration of the Enhanced Product Exclusive Evaluation Period, then, in such event, USSC shall have Rights with respect to such Enhanced Product provided and for so long as USSC shall agree in its discretion to reimburse VITEX for ***** ************* of VITEX's documented and agreed upon direct research and development costs (i.e. ****************************************************** **********************) for such Enhanced Product occurring on and after such notice date and prior to the design and submission for regulatory approval of Phase III clinical trials and further provided that within thirty (30) days of exercise of such option VITEX and USSC have agreed in writing upon the transfer price for such Enhanced Product which agreement shall be negotiated in good faith, but the failure of the parties to so agree shall not result in the loss of USSC's Rights with respect to such Enha...